Exact Mass: 502.2023
Exact Mass Matches: 502.2023
Found 500 metabolites which its exact mass value is equals to given mass value 502.2023
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Verrucarin A
A trichothecene antibiotic which incorporates a triester macrocyclic structure and an exocyclic methylene epoxide group. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D000970 - Antineoplastic Agents
Cycloheterophyllin
Cycloheterophyllin is an extended flavonoid. Cycloheterophyllin is a natural product found in Artocarpus integer and Artocarpus lowii with data available. Cycloheterophyllin is found in fruits. Cycloheterophyllin is isolated from bark of Artocarpus heterophyllus (jackfruit Isolated from bark of Artocarpus heterophyllus (jackfruit). Cycloheterophyllin is found in jackfruit and fruits.
Cyclocalamin
Cyclocalamin is found in citrus. Cyclocalamin is a constituent of calamondin seeds (Citrus reticulata var. austera x Fortunella sp.)
Isocyclocalamin
Isocyclocalamin is found in citrus. Isocyclocalamin is a constituent of a Citrus reticulata/Fortunella hybrid. Constituent of a Citrus reticulata/Fortunella hybrid. Isocyclocalamin is found in citrus.
Artonin B
Artonin B is found in fruits. Artonin B is a constituent of Artocarpus heterophyllus (jackfruit) Constituent of Artocarpus heterophyllus (jackfruit). Artonin B is found in fruits.
Isocycloheterophyllin
Isocycloheterophyllin is found in fruits. Isocycloheterophyllin is a constituent of wood of Artocarpus heterophyllus (jackfruit)
Artonin A
Artonin A is found in fruits. Artonin A is a constituent of Artocarpus heterophyllus (jackfruit) Constituent of Artocarpus heterophyllus (jackfruit). Artonin A is found in fruits.
Artonin F
Artonin F is found in breadfruit. Artonin F is a constituent of Artocarpus communis (breadfruit). Constituent of Artocarpus communis (breadfruit). Artonin F is found in breadfruit and fruits.
Isoglobotriaose
Isoglobotriaose is a glycosphingolipid found in mammalian tissues; nonepithelial residue in the intestine, spleen, and spleen microsomes. (PMID: 7053385, 893368, 4690582). Globotriaosylceramide receptors bind to Verotoxin 1 (VT1) B subunits from Escherichia coli eliciting human vascular disease as a consequence of specific binding to these receptors on endothelial cell surfaces. (PMID: 10361298, 10353828). Globotriaosylceramides accumulate in patients with Fabry disease. Fabry disease is a X-linked metabolic disorder caused by a deficiency of alpha-galactosidase leading to the systemic accumulation of glycosphingolipids with alpha-galactosyl moieties; glycolipid deposition in endothelial cells leads to renal failure and cardiac and cerebrovascular disease. (PMID: 10339603). Isoglobotriaose is a glycosphingolipid found in mammalian tissues; nonepithelial residue in the intestine, spleen, and spleen microsomes. (PMID: 7053385, 893368, 4690582)
Ac-DEVD-CHO
Elastase Inhibitor III
Asp f I
[3aR-[3aR*,4R*[E(E)],6E,9R*,10Z,11aR*]]-2-[[[9-(Acetyloxy)-2,3,3a,4,5,8,9,11a-octahydro-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl]oxy]carbonyl]-2-butenyl ester 2-(hydroxymethyl)-2-butenoic acid
Gochnatiolide A
Geranioloxyalatum flavone
Euchretin J
[3aR-[3aR*,4R*[E(E)],6E,9S*,10Z,11aR*]]-2-[[[9-(acetyloxy)-2,3,3a,4,5,8,9,11a-octahydro-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl]oxy]carbonyl]-2-butenyl ester 2-(hydroxymethyl)-2-Butenoic acid
Cycloheterophyllin
2,6-dimethoxy-4-(prop-2-enyl)phenyl alpha-L-rhamnopyranosyl-(1<*>6)-beta-D-glucopyranoside
1,2,alpha-dihydro-5beta-hydroxy-6alpha,7alpha-epoxy-resiniferonol-14-benzoate
(5R,8Z,11Z)-5-(6-O-malonyl-beta-D-glucopyranosyloxy)-6-oxotetradeca-8,11-dienoic acid
2,6-dimethoxy-4-[(1E)-prop-1-enyl]phenyl alpha-L-rhamnopyranosyl-(1<*>6)-beta-D-glucopyranoside
(3aS,4S,4aR,5S,6S,8S,8aS,9S)-5-[(acetyloxy)methyl]-4-(benzoyloxy)-2,3,4,4a,5,6,7,8,8a,9-decahydro-5,6,8,9-tetrahydroxy-1,8a,12,12-tetramethyl-3a,9-(methanoxymethano)-3aH-benz[f]inden-10-one|tasumatrol R
1,4-di-O-beta-D-glucopyranosyl-2-(1,1-dimethylpropenyl)benzene
(-)-(3S,6E)-1,9-bis(p-hydroxyphenyl)-3-hydroxynon-6-en-5-one 3-O-beta-D-glucoside|6,7-anhydroericaone 3-O-beta-D-glucoside
1,5-Bis(beta-D-glucopyranosyloxy)-2-(3,3-dimethylallyl) benzene|1,5-Bis(??-D-glucopyranosyloxy-2-(3,3-dimethylallyl) benzene
1,3-di-O-beta-glucopyranosyloxy-4-(1,1-dimethyl-2-propenyl)benzene|JBIR-37
(3S,6R,7R,8R)-3-Hydroxy-8-<5-(5-acetoxytiglyloxy)-tiglyloxy>-helianga-1(10),5,11(13)-trien-6,12-olide|(3S,6R,7R,8R)-3-Hydroxy-8-[5-(5-acetoxytiglyloxy)-tiglyloxy]-helianga-1(10),5,11(13)-trien-6,12-olide
(aS,5S,6S,7S)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-5-[isobutyryl]oxybenzodioxolo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol|schisanwilsonin E
C27H34O9_2-Butenoic acid, 2-(hydroxymethyl)-, (2E)-2-[[[(3aR,4R,6E,9S,10Z,11aS)-9-(acetyloxy)-2,3,3a,4,5,8,9,11a-octahydro-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl]oxy]carbonyl]-2-buten-1-yl ester, (2E)
Ala Cys Phe Tyr
Ala Cys Tyr Phe
Ala Glu Phe His
Ala Glu His Phe
Ala Phe Cys Tyr
Ala Phe Glu His
Ala Phe His Glu
Ala Phe Tyr Cys
Ala His Glu Phe
Ala His Phe Glu
Ala Ser Tyr Tyr
Ala Tyr Cys Phe
Ala Tyr Phe Cys
Ala Tyr Ser Tyr
Ala Tyr Tyr Ser
Cys Ala Phe Tyr
Cys Ala Tyr Phe
Cys Phe Ala Tyr
Cys Phe Phe Ser
Cys Phe His Pro
Cys Phe Pro His
Cys Phe Ser Phe
Cys Phe Tyr Ala
Cys His Phe Pro
Cys His Ile Met
Cys His Leu Met
Cys His Met Ile
Cys His Met Leu
Cys His Pro Phe
Cys Ile His Met
Cys Ile Met His
Cys Leu His Met
Cys Leu Met His
Cys Met His Ile
Cys Met His Leu
Cys Met Ile His
Cys Met Leu His
Cys Pro Phe His
Cys Pro His Phe
Cys Ser Phe Phe
Cys Tyr Ala Phe
Cys Tyr Phe Ala
Asp His Met Thr
Asp His Thr Met
Asp Met His Thr
Asp Met Thr His
Asp Thr His Met
Asp Thr Met His
Glu Ala Phe His
Glu Ala His Phe
Glu Glu Glu Pro
Glu Glu Pro Glu
Glu Phe Ala His
Glu Phe His Ala
Glu His Ala Phe
Glu His Phe Ala
Glu His Met Ser
Glu His Ser Met
Glu Met His Ser
Glu Met Ser His
Glu Pro Glu Glu
Glu Ser His Met
Glu Ser Met His
Phe Ala Cys Tyr
Phe Ala Glu His
Phe Ala His Glu
Phe Ala Tyr Cys
Phe Cys Ala Tyr
Phe Cys Phe Ser
Phe Cys His Pro
Phe Cys Pro His
Phe Cys Ser Phe
Phe Cys Tyr Ala
Phe Glu Ala His
Phe Glu His Ala
Phe Phe Cys Ser
Phe Phe Ser Cys
Phe His Ala Glu
Phe His Cys Pro
Phe His Glu Ala
Phe His Pro Cys
Phe Pro Cys His
Phe Pro His Cys
Phe Ser Cys Phe
Phe Ser Phe Cys
Phe Ser Ser Tyr
Phe Ser Tyr Ser
Phe Tyr Ala Cys
Phe Tyr Cys Ala
Phe Tyr Ser Ser
Gly Thr Tyr Tyr
Gly Tyr Thr Tyr
Gly Tyr Tyr Thr
His Ala Glu Phe
His Ala Phe Glu
His Cys Phe Pro
His Cys Ile Met
His Cys Leu Met
His Cys Met Ile
His Cys Met Leu
His Cys Pro Phe
His Asp Met Thr
His Asp Thr Met
His Glu Ala Phe
His Glu Phe Ala
His Glu Met Ser
His Glu Ser Met
His Phe Ala Glu
His Phe Cys Pro
His Phe Glu Ala
His Phe Pro Cys
His Ile Cys Met
His Ile Met Cys
His Leu Cys Met
His Leu Met Cys
His Met Cys Ile
His Met Cys Leu
His Met Asp Thr
His Met Glu Ser
His Met Ile Cys
His Met Leu Cys
His Met Ser Glu
His Met Thr Asp
His Pro Cys Phe
His Pro Phe Cys
His Pro Ser Tyr
His Pro Tyr Ser
His Ser Glu Met
His Ser Met Glu
His Ser Pro Tyr
His Ser Tyr Pro
His Thr Asp Met
His Thr Met Asp
His Tyr Pro Ser
His Tyr Ser Pro
Ile Cys His Met
Ile Cys Met His
Ile His Cys Met
Ile His Met Cys
Ile Met Cys His
Ile Met His Cys
Leu Cys His Met
Leu Cys Met His
Leu His Cys Met
Leu His Met Cys
Leu Met Cys His
Leu Met His Cys
Met Cys His Ile
Met Cys His Leu
Met Cys Ile His
Met Cys Leu His
Met Asp His Thr
Met Asp Thr His
Met Glu His Ser
Met Glu Ser His
Met His Cys Ile
Met His Cys Leu
Met His Asp Thr
Met His Glu Ser
Met His Ile Cys
Met His Leu Cys
Met His Ser Glu
Met His Thr Asp
Met Ile Cys His
Met Ile His Cys
Met Leu Cys His
Met Leu His Cys
Met Ser Glu His
Met Ser His Glu
Met Thr Asp His
Met Thr His Asp
Asn Asn Gln Gln
Asn Pro Ser Trp
Asn Pro Trp Ser
Asn Gln Asn Gln
Asn Gln Gln Asn
Asn Ser Pro Trp
Asn Ser Trp Pro
Asn Trp Pro Ser
Asn Trp Ser Pro
Pro Cys Phe His
Pro Cys His Phe
Pro Glu Glu Glu
Pro Phe Cys His
Pro Phe His Cys
Pro His Cys Phe
Pro His Phe Cys
Pro His Ser Tyr
Pro His Tyr Ser
Pro Asn Ser Trp
Pro Asn Trp Ser
Pro Ser His Tyr
Pro Ser Asn Trp
Pro Ser Trp Asn
Pro Ser Tyr His
Pro Trp Asn Ser
Pro Trp Ser Asn
Pro Tyr His Ser
Pro Tyr Ser His
Gln Asn Asn Gln
Gln Asn Gln Asn
Gln Gln Asn Asn
Ser Ala Tyr Tyr
Ser Cys Phe Phe
Ser Glu His Met
Ser Glu Met His
Ser Phe Cys Phe
Ser Phe Phe Cys
Ser Phe Ser Tyr
Ser Phe Tyr Ser
Ser His Glu Met
Ser His Met Glu
Ser His Pro Tyr
Ser His Tyr Pro
Ser Met Glu His
Ser Met His Glu
Ser Asn Pro Trp
Ser Asn Trp Pro
Ser Pro His Tyr
Ser Pro Asn Trp
Ser Pro Trp Asn
Ser Pro Tyr His
Ser Ser Phe Tyr
Ser Ser Tyr Phe
Ser Trp Asn Pro
Ser Trp Pro Asn
Ser Tyr Ala Tyr
Ser Tyr Phe Ser
Ser Tyr His Pro
Ser Tyr Pro His
Ser Tyr Ser Phe
Ser Tyr Tyr Ala
Thr Asp His Met
Thr Asp Met His
Thr Gly Tyr Tyr
Thr His Asp Met
Thr His Met Asp
Thr Met Asp His
Thr Met His Asp
Thr Tyr Gly Tyr
Thr Tyr Tyr Gly
Trp Asn Pro Ser
Trp Asn Ser Pro
Trp Pro Asn Ser
Trp Pro Ser Asn
Trp Ser Asn Pro
Trp Ser Pro Asn
Tyr Ala Cys Phe
Tyr Ala Phe Cys
Tyr Ala Ser Tyr
Tyr Ala Tyr Ser
Tyr Cys Ala Phe
Tyr Cys Phe Ala
Tyr Phe Ala Cys
Tyr Phe Cys Ala
Tyr Phe Ser Ser
Tyr Gly Thr Tyr
Tyr Gly Tyr Thr
Tyr His Pro Ser
Tyr His Ser Pro
Tyr Pro His Ser
Tyr Pro Ser His
Tyr Ser Ala Tyr
Tyr Ser Phe Ser
Tyr Ser His Pro
Tyr Ser Pro His
Tyr Ser Ser Phe
Tyr Ser Tyr Ala
Tyr Thr Gly Tyr
Tyr Thr Tyr Gly
Tyr Tyr Ala Ser
Tyr Tyr Gly Thr
Tyr Tyr Ser Ala
Tyr Tyr Thr Gly
N-Ac-Asp-Glu-Val-Asp-CHO
Isoglobotriaose
Isocycloheterophyllin
Isocyclocalamin
Cyclocalamin
benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol
(6α,8ξ,11β,14ξ,16α,17α)-6,9-Difluoro-17-{[(fluoromethyl)sulfanyl] carbonyl}-11-hydroxy-16-methyl-3-oxoandrost-4-en-17-yl propionate
[(2R,3R,4R,5R)-4-acetyloxy-1-[tert-butyl(diphenyl)silyl]oxy-2,5-dihydroxy-6-oxohexan-3-yl] acetate
(S)-Ethyl-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoate oxalate
Ac-DEVD-CHO
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors Ac-DEVD-CHO is a specific Caspase-3 inhibitor with a Ki value of 230 pM.
1-[5-Chloro-2-(trifluoromethyl)benzyl]-7-[6-(4-methyl-1-piperazin yl)-3-pyridinyl]-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine
lanthanum(3+),1,2,3,5-tetramethylcyclopenta-1,3-diene
Forxiga
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor
Methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones
3-Bodipy-propanoylaminocaproic Acid, N-Hydroxysuccinimide Ester
(1E,2E,4E,6R)-1-(2,4-dioxopyrrolidin-3-ylidene)-6-[(2R,3S,3aS,5R,6R,7S,9aS)-3-(methoxycarbonyl)-2,6,9a-trimethyl-8-oxooctahydro-3a,7-epoxyfuro[3,2-b]oxocin-5-yl]-4-methylhepta-2,4-dien-1-olate
4-[[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
4-[[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl-methylamino]methyl]benzoic acid
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
(3R,6aR,8S,10aR)-N-(4-chlorophenyl)-3-hydroxy-8-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] undecanoate
[(E)-2-[[(3aR,4R,6E,9S,11aS)-9-acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl]oxycarbonyl]but-2-enyl] (E)-2-(hydroxymethyl)but-2-enoate
(2R,3R,4R,5R)-4-{[(2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(1S,2R,3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}oxan-2-yl]oxy}-2,3,5,6-tetrahydroxyhexanal
nocamycin I(1-)
An organic anion resulting from the deprotonation of the enol moiety of nocamycin I. The major species at pH 7.3.
CCG258747
CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1]. CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1].
(1s,2r,6r,7r,9r,14r,16r,17r)-6-hydroxy-14-[(2s,3r)-3-(hydroxymethyl)-5-oxooxolan-2-yl]-2,6,14,17-tetramethyl-3,11-dioxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-4,12-dien-16-yl acetate
methyl 2-[(1r,2r,4s,7s,8s,11r,12r,13s,16r,17s)-7-(furan-3-yl)-17-hydroxy-1,8,12,15,15-pentamethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-13-yl]acetate
methyl 2-[6-(furan-3-yl)-10-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7,18-dioxapentacyclo[11.3.1.1¹¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-16-yl]-2-hydroxyacetate
methyl 2-[(1s,2s,3s,7s,8s,12r,14r,15s,16r,17s,18s)-8-(furan-3-yl)-1,3,15-trihydroxy-7,16,18-trimethyl-10-oxo-9,13-dioxahexacyclo[14.2.1.0²,¹⁴.0³,¹².0⁴,¹⁸.0⁷,¹²]nonadecan-17-yl]acetate
(16s,17s)-16-(4-hydroxy-3-methoxyphenyl)-17-(hydroxymethyl)-13-isopropyl-7,7-dimethyl-15,18-dioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),2,4,8,11,13-hexaene-6,10-dione
methyl (2r)-2-[(1s,2r,5r,6r,10r,11s,13s,16s)-6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadecan-16-yl]-2-hydroxyacetate
(16r,17s)-16-(4-hydroxy-3-methoxyphenyl)-17-(hydroxymethyl)-13-isopropyl-7,7-dimethyl-15,18-dioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),2,4,8,11,13-hexaene-6,10-dione
(17r)-12,21,23-trihydroxy-8,8,18,18-tetramethyl-5-(3-methylbut-2-en-1-yl)-3,7,19-trioxahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(23),2(15),4,6(11),9,12,20(24),21-octaen-14-one
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[4-(3-methylbut-2-en-1-yl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy]oxane-3,4,5-triol
(11s)-6,7,15-trihydroxy-19,19-dimethyl-22-(3-methylbut-2-en-1-yl)-11-(2-methylprop-1-en-1-yl)-2,10,20-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4,6,8,14,16(21),17-octaen-13-one
(1s,2r,6s,7r,9r,14r,16r,17r)-6-hydroxy-14-[(2s,3r)-3-(hydroxymethyl)-5-oxooxolan-2-yl]-2,6,14,17-tetramethyl-3,11-dioxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-4,12-dien-16-yl acetate
(1's,2's,3as,6's,6ar,9r,9'r,9ar,9bs)-9'-hydroxy-3,5',6,15'-tetramethylidene-4,5,6a,7,9a,9b-hexahydro-3ah-3'-oxaspiro[azuleno[4,5-b]furan-9,12'-tetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadecan]-13'(16')-ene-2,4',8,14'-tetrone
(3ar,4r,9r,11as)-9-(acetyloxy)-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl (2e)-4-hydroxy-2-({[(2e)-2-methylbut-2-enoyl]oxy}methyl)but-2-enoate
(1r,5s,6r)-5,6-dihydroxy-4-methoxy-2-oxocyclohex-3-en-1-yl (4as,7r,8s)-7-ethenyl-8,10-dihydroxy-1,1,7-trimethyl-9-oxo-2,3,4,5,6,8-hexahydrophenanthrene-4a-carboxylate
(17r)-12,21,23-trihydroxy-8,8,18,18-tetramethyl-11-(3-methylbut-2-en-1-yl)-3,9,19-trioxahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁵,¹⁰.0²⁰,²⁴]tetracosa-1(23),2(15),4,6,10,12,20(24),21-octaen-14-one
methyl 2-[6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadecan-16-yl]-2-hydroxyacetate
(7r,16r)-11,18,19,21-tetrahydroxy-7-methyl-7-(4-methylpent-3-en-1-yl)-16-(prop-1-en-2-yl)-2,8-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-1(14),3,5,9,11,17,19,21-octaen-13-one
(3s,4r,7r,9s,10s,12s,13s,15s,16r,17r,20s)-18-[(3r,4r)-3,4-dimethyl-5-oxooxolan-2-yl]-9,17-dihydroxy-4,17-dimethyl-19,21,22-trioxaheptacyclo[11.6.1.1¹,¹⁵.1⁷,¹⁰.0³,¹².0⁴,⁹.0¹⁶,²⁰]docosane-5,8-dione
(1'r,2's,3as,6's,6ar,9s,9's,9ar,9bs)-9'-hydroxy-3,5',6,15'-tetramethylidene-4,5,6a,7,9a,9b-hexahydro-3ah-3'-oxaspiro[azuleno[4,5-b]furan-9,12'-tetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadecan]-13'(16')-ene-2,4',8,14'-tetrone
3β-angeloyloxy-8-oxoeremophila-6,9-dien-12-oicacid ethyl ester
{"Ingredient_id": "HBIN008190","Ingredient_name": "3\u03b2-angeloyloxy-8-oxoeremophila-6,9-dien-12-oicacid ethyl ester","Alias": "NA","Ingredient_formula": "C27H34O9","Ingredient_Smile": "CC1=C2C3(CC1)C(C4C(C2(C(=O)OC3(C)C)O)(C(CC(C4(CO)O)OC(=O)C5=CC=CC=C5)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1231","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}